AC Immune SA Ownership | Who Owns AC Immune SA?
AC Immune SA Ownership Summary
AC Immune SA is owned by 28.24% institutional investors, 21.83% insiders, and 49.92% retail investors. Bvf inc/il is the largest institutional shareholder, holding 18.95% of ACIU shares. BlackRock Health Sciences Opps Inv A is the top mutual fund, with 1.09% of its assets in AC Immune SA shares.
ACIU Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | AC Immune SA | 28.24% | 21.83% | 49.92% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bvf inc/il | 18.83M | 18.95% | $75.15M |
Blackrock | 2.61M | 2.62% | $10.40M |
Redmile group | 1.81M | 1.82% | $7.21M |
Wells fargo & company/mn | 1.12M | 1.13% | $4.48M |
Platinum investment management | 952.07K | 0.96% | $3.80M |
Renaissance | 652.08K | 0.66% | $2.60M |
Assenagon asset management | 439.73K | 0.44% | $1.75M |
Deutsche bank ag\ | 253.38K | 0.25% | $1.01M |
Handelsbanken fonder ab | 150.00K | 0.15% | $598.00K |
Millennium management | 106.36K | 0.11% | $424.39K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bvf inc/il | 18.83M | 2.11% | $75.15M |
Redmile group | 1.81M | 0.44% | $7.21M |
Platinum investment management | 952.07K | 0.15% | $3.80M |
Silverberg bernstein capital management | 10.00K | 0.04% | $39.90K |
Eversept partners, lp | 99.31K | 0.03% | $396.26K |
China universal asset management | 11.62K | 0.01% | $46.37K |
Renaissance | 652.08K | 0.00% | $2.60M |
Banque cantonale vaudoise | 25.42K | 0.00% | $101.00K |
Assenagon asset management | 439.73K | 0.00% | $1.75M |
Jump financial | 41.32K | 0.00% | $164.87K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bvf inc/il | 18.83M | 2.11% | 4.26M |
Assenagon asset management | 439.73K | 0.00% | 328.31K |
Renaissance | 652.08K | 0.00% | 136.30K |
Millennium management | 106.36K | 0.00% | 106.36K |
Two sigma investments, lp | 99.34K | 0.00% | 99.34K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 78.67K | - | -1.31M |
Avidity partners management lp | - | - | -825.00K |
Redmile group | 1.81M | 0.44% | -199.33K |
Platinum investment management | 952.07K | 0.15% | -142.96K |
Landscape capital management | - | - | -117.42K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Millennium management | 106.36K | 0.00% | 106.36K | $424.39K |
Two sigma investments, lp | 99.34K | 0.00% | 99.34K | $396.38K |
Alps advisors | 77.38K | 0.00% | 77.38K | $308.73K |
Cubist systematic strategies | 54.61K | 0.00% | 54.61K | $217.89K |
Jump financial | 41.32K | 0.00% | 41.32K | $164.87K |
Sold Out
Holder | Change |
---|---|
Farther finance advisors | -10.00 |
Qube research | -48.00 |
Simplex trading | -635.00 |
Lazard asset management | -10.26K |
Schonfeld strategic advisors | -11.40K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 47 | -2.08% | 28,199,176 | -1.31% | 28 | 3.42% | 14 | -39.13% | 20 | 25.00% |
Jun 30, 2024 | 48 | 17.07% | 28,573,535 | -1.35% | 28 | 2.46% | 23 | - | 16 | 128.57% |
Mar 31, 2024 | 41 | 13.89% | 28,964,504 | -2.27% | 34 | 2.79% | 23 | 9.52% | 7 | 133.33% |
Dec 31, 2023 | 36 | 12.50% | 29,638,667 | 85.45% | 34 | 9.81% | 21 | 90.91% | 3 | -40.00% |
Sep 30, 2023 | 32 | -13.51% | 15,981,631 | -0.32% | 18 | 5.14% | 11 | -21.43% | 5 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BlackRock Health Sciences Opps Inv A | 1.08M | 1.09% | - |
BlackRock Health Sciences Term Trust | 781.68K | 0.79% | 29.30K |
iShares Biotechnology ETF | 434.69K | 0.44% | -2.60K |
Handelsbanken Europa Småbolag (A1 SEK) | 360.00K | 0.36% | - |
DWS ESG Biotech LC | 253.38K | 0.26% | 1.00 |
Monega ARIAD Innovation R | 209.57K | 0.21% | - |
BlackRock Health Sciences | 78.18K | 0.08% | - |
ALPS Medical Breakthroughs ETF | 77.89K | 0.08% | - |
Fidelity Nasdaq Composite Index | 58.30K | 0.06% | - |
iShares Nasdaq US Biotech ETF USD Acc | 53.83K | 0.05% | - |
ACIU Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools